Participation of IIb-IIIa glycoprotein in spontaneous platelet aggregation

Bulletin of Experimental Biology and Medicine

Volumn 143, Issue 4, 2007, Pages 422-425

  Sirotkina, O V ^a   Zabotina, A M ^a   Taraskina, A E ^a   Sivachenko, E B ^b   Zueva, E E ^b   Kadinskaya, M I ^b   Buryachkovskaya, L I ^c   Uchitel', I A ^c   Khaspekova, S G ^c   Vavilova, T V ^b   Shvartsman, A L ^a   Mazurov, A V ^c  

^a RUSSIAN ACADEMY OF SCIENCES   (Russian Federation)

^b PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^c Federal Agency for Health Care and Social Development   (Russian Federation)

Author keywords

Genetic polymorphism; Glycoprotein Ib; Glycoprotein IIb IIIa; Platelets; Spontaneous aggregation

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOGEN; FIBRINOGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCOPROTEIN IB; LYSINE; MONAFRAM; PROLINE; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

AMINO ACID SUBSTITUTION; ANTIGEN BINDING; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; GENETIC POLYMORPHISM; HUMAN; PATHOPHYSIOLOGY; PROTEIN PROTEIN INTERACTION; STABLE ANGINA PECTORIS; THROMBOCYTE AGGREGATION; THROMBOCYTE MEMBRANE; UNSTABLE ANGINA PECTORIS;

ANTIBODIES, MONOCLONAL; ASPIRIN; BLOOD PLATELETS; CARDIOVASCULAR DISEASES; FIBRINOGEN; HUMANS; MUTATION; PEPTIDE FRAGMENTS; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POLYMORPHISM, GENETIC; PROTEIN BINDING; VON WILLEBRAND FACTOR;

ANGINA;

EID: 34648835364     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-007-0146-3     Document Type: Article

References (13)

1. O. A. Berkovich, E. A. Bazhenova, O. V. Sirotkina, et al., Med. Akad. Zh., 2, No. 3, 1-3 (2002).
2. T. V. Byzova, T. N. Vlasik, and A. V. Mazurov, Byull. Eksp. Biol. Med., 118, No. 10, 402-405 (1994).
3. A. V. Mazurov, D. V. Pevzner, T. N. Vlasik, and M. Ya. Ruda, Ros. Fiziol. Zh., 90, No. 5, 586-599 (2004).
4. O. V. Sirotkina, A. M. Sheidina, M. V. Volkova, et al., Med. Akad. Zh., 4, No. 1, 29-35 (2004).
5. N. K. Breddin, R. Lippold, M. Bittner, et al., Atheroscle-rosis, 144, No. 1, 211-219 (1999).
6. A. Di Castelnuovo, G. de Gaetano, M. B. Donati, and L. Iacoviello, Thromb. Haemost., 85, No. 4, 626-633 (2001).
7. D. Feng, K. Lindpaintner, M. G. Larson, et al., Arterioscler. Thromb. Vasc. Biol., 19, No. 4, 1142-1147 (1999).
8. Y. Fusegawa, S. Goto, S. Handa, et al., Thromb. Res., 93, No. 6, 271-278 (1999).
9. M. J. Quinn, T. V. Byzova, J. Qin, et al., Arterioscler. Thromb. Vasc. Biol., 23, No. 6, 945-952 (2003).
10. Z. M. Ruggeri, J. Thromb. Haemost., 1, No. 7, 1335-1342 (2003).
11. M. D. Trip, V. M. Cats, F. J. van Cappelle, and J. Vreeken, N. Engl. J. Med., 322, No. 22, 1549-1554 (1990).
12. K. V. Vijayan, P. J. Goldschmidt-Clermont, C. Roos, and P. F. Bray, J. Clin. Invest., 105, No. 6, 793-802 (2000).
13. E. J. Weiss, P. P. Bray, M. Tayback, et al., N. Engl. J. Med., 334, No. 17, 1090-1094 (1996).